BackMarrone Bio Innovations Overview

Marrone Bio Innovations EBIT

EBIT (Earnings Before Interest and Taxes) analysis for MBII.

Quarterly EBIT

-$7.06M
149.59% YoY

As of Mar 31, 2022

Annual EBIT (TTM)

-$19.17M
75.26% YoY

Trailing 12 months ending Mar 31, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)